← brief for 2026-09-16 · Slowing decline

Prior GLP-1RA or Tirzepatide Use and Early Cardiorenal Outcomes After Metabolic and Bariatric Surgery.

Article C Peer reviewed Observational

Key takeaways

A review of medical records found that people who took GLP-1 drugs or tirzepatide before metabolic surgery had different early heart and kidney outcomes than those who did not — but this study shows a link, not proof that the drugs caused the difference.

Who did this work

Tseng TC · Chang R

Source

Article · PubMed, the drug frontier · 2026 Sep 14
https://pubmed.ncbi.nlm.nih.gov/42735883/